BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 16834767)

  • 1. High-throughput genomic technology in research and clinical management of breast cancer. Evolving landscape of genetic epidemiological studies.
    Low YL; Wedrén S; Liu J
    Breast Cancer Res; 2006; 8(3):209. PubMed ID: 16834767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Advances in high-density whole genome-wide single nucleotide polymorphism array in cancer research].
    Zeng ZY; Xiong W; Zhou YH; Li XL; Li GY
    Ai Zheng; 2006 Nov; 25(11):1454-8. PubMed ID: 17094921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers.
    Walker LC; Waddell N; Ten Haaf A; ; Grimmond S; Spurdle AB
    Breast Cancer Res Treat; 2008 Nov; 112(2):229-36. PubMed ID: 18095154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERCC4 associated with breast cancer risk: a two-stage case-control study using high-throughput genotyping.
    Milne RL; Ribas G; González-Neira A; Fagerholm R; Salas A; González E; Dopazo J; Nevanlinna H; Robledo M; Benítez J
    Cancer Res; 2006 Oct; 66(19):9420-7. PubMed ID: 17018596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targets of genome copy number reduction in primary breast cancers identified by integrative genomics.
    Chen W; Salto-Tellez M; Palanisamy N; Ganesan K; Hou Q; Tan LK; Sii LH; Ito K; Tan B; Wu J; Tay A; Tan KC; Ang E; Tan BK; Tan PH; Ito Y; Tan P
    Genes Chromosomes Cancer; 2007 Mar; 46(3):288-301. PubMed ID: 17171680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer.
    Bernig T; Chanock SJ
    Expert Rev Mol Diagn; 2006 May; 6(3):319-31. PubMed ID: 16706736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microarrays in breast cancer research and clinical practice--the future lies ahead.
    Gruvberger-Saal SK; Cunliffe HE; Carr KM; Hedenfalk IA
    Endocr Relat Cancer; 2006 Dec; 13(4):1017-31. PubMed ID: 17158752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The search for low-penetrance cancer susceptibility alleles.
    Houlston RS; Peto J
    Oncogene; 2004 Aug; 23(38):6471-6. PubMed ID: 15322517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatics and breast cancer: what can high-throughput genomic approaches actually tell us?
    Sims AH
    J Clin Pathol; 2009 Oct; 62(10):879-85. PubMed ID: 19174421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microarray-based DNA profiling to study genomic aberrations.
    Waddell N
    IUBMB Life; 2008 Jul; 60(7):437-40. PubMed ID: 18553550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single nucleotide polymorphisms and breast cancer: not yet a success story.
    Tamimi RM
    Breast Cancer Res; 2006; 8(4):108. PubMed ID: 16887007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating new candidate SNPs as low penetrance risk factors in sporadic breast cancer: a two-stage Spanish case-control study.
    Vega A; Salas A; Milne RL; Carracedo B; Ribas G; Ruibal A; de León AC; González-Hernández A; Benítez J; Carracedo A
    Gynecol Oncol; 2009 Jan; 112(1):210-4. PubMed ID: 18950845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genetics and genomics of cancer.
    Balmain A; Gray J; Ponder B
    Nat Genet; 2003 Mar; 33 Suppl():238-44. PubMed ID: 12610533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primer: genomic and proteomic tools for the molecular dissection of disease.
    Walker EJ; Siminovitch KA
    Nat Clin Pract Rheumatol; 2007 Oct; 3(10):580-9. PubMed ID: 17906613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-genome amplification of oral rinse self-collected DNA in a population-based case-control study of breast cancer.
    Liang X; Trentham-Dietz A; Titus-Ernstoff L; Newcomb PA; Welch RA; Hutchinson AA; Hampton JM; Sutcliffe CB; Haines JL; Egan KM
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1610-4. PubMed ID: 17684135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From chromosomal alterations to target genes for therapy: integrating cytogenetic and functional genomic views of the breast cancer genome.
    Monni O; Hyman E; Mousses S; Barlund M; Kallioniemi A; Kallioniemi OP
    Semin Cancer Biol; 2001 Oct; 11(5):395-401. PubMed ID: 11562182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of array-based genomic and epigenomic technologies to unraveling the heterogeneous nature of breast tumors: on the road to individualized treatment.
    Abramovitz M; Leyland-Jones B
    Cancer Genomics Proteomics; 2007; 4(3):135-45. PubMed ID: 17878517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent development in pharmacogenomics: from candidate genes to genome-wide association studies.
    Grant SF; Hakonarson H
    Expert Rev Mol Diagn; 2007 Jul; 7(4):371-93. PubMed ID: 17620046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.